Leonard Kaps

1.7k total citations
66 papers, 1.2k citations indexed

About

Leonard Kaps is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Leonard Kaps has authored 66 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hepatology, 23 papers in Epidemiology and 17 papers in Molecular Biology. Recurrent topics in Leonard Kaps's work include Liver Disease Diagnosis and Treatment (22 papers), Liver Disease and Transplantation (18 papers) and RNA Interference and Gene Delivery (14 papers). Leonard Kaps is often cited by papers focused on Liver Disease Diagnosis and Treatment (22 papers), Liver Disease and Transplantation (18 papers) and RNA Interference and Gene Delivery (14 papers). Leonard Kaps collaborates with scholars based in Germany, United States and Belgium. Leonard Kaps's co-authors include Detlef Schuppan, Peter R. Galle, Christian Labenz, Jörn M. Schattenberg, Maurice Stephan Michel, Rainer Schobert, Lutz Nuhn, Bernhard Biersack, Rudolf Zentel and Markus Moehler and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Leonard Kaps

61 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leonard Kaps Germany 19 318 295 234 234 229 66 1.2k
Anna Massaguer Spain 26 488 1.5× 302 1.0× 463 2.0× 289 1.2× 262 1.1× 58 1.5k
Zhong‐Xia Wang China 18 502 1.6× 111 0.4× 196 0.8× 131 0.6× 160 0.7× 51 1.2k
Xiyu Liu China 20 282 0.9× 157 0.5× 271 1.2× 78 0.3× 87 0.4× 55 1.0k
Ashutosh Barve United States 15 295 0.9× 54 0.2× 147 0.6× 113 0.5× 200 0.9× 26 910
Lissa Hooi Singapore 16 297 0.9× 55 0.2× 245 1.0× 71 0.3× 79 0.3× 27 850
Qianqian Yu China 21 552 1.7× 102 0.3× 218 0.9× 38 0.2× 49 0.2× 37 1.0k
Zancong Shen United States 20 309 1.0× 58 0.2× 108 0.5× 77 0.3× 100 0.4× 45 1.3k
Michael J. Gerber United States 17 122 0.4× 108 0.4× 86 0.4× 153 0.7× 124 0.5× 22 1.5k
Manuel Álvarez Chile 24 774 2.4× 126 0.4× 879 3.8× 182 0.8× 450 2.0× 63 2.1k
N. Willmott United Kingdom 20 458 1.4× 91 0.3× 391 1.7× 125 0.5× 43 0.2× 64 1.3k

Countries citing papers authored by Leonard Kaps

Since Specialization
Citations

This map shows the geographic impact of Leonard Kaps's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonard Kaps with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonard Kaps more than expected).

Fields of papers citing papers by Leonard Kaps

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leonard Kaps. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonard Kaps. The network helps show where Leonard Kaps may publish in the future.

Co-authorship network of co-authors of Leonard Kaps

This figure shows the co-authorship network connecting the top 25 collaborators of Leonard Kaps. A scholar is included among the top collaborators of Leonard Kaps based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leonard Kaps. Leonard Kaps is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fuchs, Alexander, Michael Fichter, Pia Winterwerber, et al.. (2026). Biodegradable Carbonate Nanogels Loaded with Anti MFAP‐5 siRNA for Anti‐stromal Therapy of Hepatocellular Carcinoma. Advanced Science. e10006–e10006.
2.
Fichter, Michael, Alexander Fuchs, Paul M. Schneider, et al.. (2025). Unfolding and Degradation of Micellar Immunodrug Carriers Derived From End Group Modified Aliphatic Poly(Carbonate)s with Acid‐Responsive Ketal Side Groups. Advanced Materials. 38(8). e11752–e11752.
3.
Karataylı, Ersin, et al.. (2025). Curcumin and Its Derivatives in Hepatology: Therapeutic Potential and Advances in Nanoparticle Formulations. Cancers. 17(3). 484–484. 2 indexed citations
4.
Schneider, Paul M., Michael Fichter, Federica De Lorenzi, et al.. (2024). A hepatocellular carcinoma model with and without parenchymal liver damage that integrates technical and pathophysiological advantages for therapy testing. Pharmacological Research. 211. 107560–107560. 2 indexed citations
5.
Labenz, Christian, Simon Johannes Gairing, Leonard Kaps, et al.. (2024). QuickStroop for screening for minimal hepatic encephalopathy in patients with cirrhosis. JHEP Reports. 7(3). 101298–101298.
6.
Santis, Daniele De, Diana Moeckel, Leonard Kaps, et al.. (2023). Repurposing Tamoxifen for Tumor Microenvironment Priming and Enhanced Tumor‐Targeted Drug Delivery. Advanced Therapeutics. 6(11). 1 indexed citations
7.
Schneider, Paul M., Hua Zhang, Ömer Öztürk, et al.. (2023). In vivo gene silencing with novel siRNA loaded polypeptoide nanoparticles for anti-stromal therapy in hepatocellular carcinoma. Zeitschrift für Gastroenterologie. 61(8). e492–e493. 1 indexed citations
8.
Kaps, Leonard, Paul M. Schneider, Ion Andronache, et al.. (2023). A New Synthetic Curcuminoid Displays Antitumor Activities in Metastasized Melanoma. Cells. 12(22). 2619–2619. 7 indexed citations
9.
Kaps, Leonard, Paul M. Schneider, Maximiliano L. Cacicedo, et al.. (2023). Liver Cell Type-Specific Targeting by Nanoformulations for Therapeutic Applications. International Journal of Molecular Sciences. 24(14). 11869–11869. 7 indexed citations
10.
Michel, Maurice Stephan, Christian Labenz, Angelo Armandi, et al.. (2023). Metabolic dysfunction-associated fatty liver disease in people living with HIV. Scientific Reports. 13(1). 9158–9158. 7 indexed citations
11.
Lorenzi, Federica De, Larissa Yokota Rizzo, Maike Baues, et al.. (2022). Profiling target engagement and cellular uptake of cRGD-decorated clinical-stage core-crosslinked polymeric micelles. Drug Delivery and Translational Research. 13(5). 1195–1211. 10 indexed citations
12.
Kaps, Leonard, Michael Nagel, Maurice Stephan Michel, et al.. (2022). Validation of EncephalApp_Stroop as screening tool for the detection of minimal hepatic encephalopathy in German patients with liver cirrhosis. Clinics and Research in Hepatology and Gastroenterology. 46(4). 101873–101873. 5 indexed citations
13.
Kaps, Leonard, Michael Nagel, Maurice Stephan Michel, et al.. (2021). Risk factors for poorer health literacy in patients with liver cirrhosis. PLoS ONE. 16(7). e0255349–e0255349. 21 indexed citations
14.
Schaller, David, Leonard Kaps, Detlef Schuppan, et al.. (2021). New 3-Aryl-2-(2-thienyl)acrylonitriles with High Activity Against Hepatoma Cells. International Journal of Molecular Sciences. 22(5). 2243–2243. 8 indexed citations
15.
Michel, Maurice Stephan, Francesca Romana Spinelli, Annette Grambihler, et al.. (2021). Health-related quality of life in patients with autoimmune hepatitis. Quality of Life Research. 30(10). 2853–2861. 5 indexed citations
16.
Kaps, Leonard, Christian Labenz, Peter R. Galle, et al.. (2020). Non‐alcoholic fatty liver disease increases the risk of incident chronic kidney disease. United European Gastroenterology Journal. 8(8). 942–948. 43 indexed citations
17.
Labenz, Christian, Karel Kostev, Leonard Kaps, Peter R. Galle, & Jörn M. Schattenberg. (2020). Incident Dementia in Elderly Patients with Nonalcoholic Fatty Liver Disease in Germany. Digestive Diseases and Sciences. 66(9). 3179–3185. 37 indexed citations
18.
Kaps, Leonard, Annette Grambihler, Michael Nagel, et al.. (2019). Symptom Burden and Treatment Response in Patients with Primary Biliary Cholangitis (PBC). Digestive Diseases and Sciences. 65(10). 3006–3013. 15 indexed citations
19.
Foerster, Friedrich, Sebastian Boegel, Rosario Heck, et al.. (2017). Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells. OncoImmunology. 7(4). e1409929–e1409929. 24 indexed citations
20.
Biersack, Bernhard, et al.. (2013). Synergistic gold effects of anti-vascular 4,5-diarylimidazol-2-ylidene gold(I) carbene complexes. International Journal of Clinical Pharmacology and Therapeutics. 51(1). 44–46. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Massaguer Breakdown of academic impact, for papers by Zhong‐Xia Wang Breakdown of academic impact, for papers by Xiyu Liu Breakdown of academic impact, for papers by Ashutosh Barve Breakdown of academic impact, for papers by Lissa Hooi Breakdown of academic impact, for papers by Qianqian Yu Breakdown of academic impact, for papers by Zancong Shen Breakdown of academic impact, for papers by Michael J. Gerber Breakdown of academic impact, for papers by Manuel Álvarez Breakdown of academic impact, for papers by N. Willmott
Rankless by CCL
2026